Can text messages help cancer survivors stop drinking?
NCT ID NCT05570851
First seen Jun 25, 2026 · Last updated Jul 24, 2026 · Updated 2 times
Summary
This pilot study tested whether tailored text messages could help head and neck cancer survivors stop drinking alcohol, which is a major risk factor for cancer recurrence. 126 survivors from a hospital and a VA medical center were randomly assigned to receive either the text message program or standard advice. The study measured how many people quit drinking after 3 and 6 months, and whether the approach was acceptable and feasible for a larger trial.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- tailored text messages promoting alcohol cessation
- What this could lead to
- If it works, this could provide a simple, scalable way to help head and neck cancer survivors quit alcohol and lower their risk of cancer recurrence.
- What could go wrong
- This is a small pilot study (126 people) testing feasibility, not effectiveness. Results may not apply to all survivors, and self-reported drinking may be inaccurate.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
126 people
The number who actually took part.
- Started
-
Dec 2023
- Finished
-
Mar 2026
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Adult male or female patients 18 years or older * Diagnosed with primary cancer of: pharynx (nasopharynx, oropharynx, hypopharynx), larynx (all subsites), oral cavity (all subsites) * Having completed surgical, radiation, and/or chemotherapy treatment; * Post-treatment completion status of at least 3 months; * Able to communicate and read in English; * Possess a telephone with text messaging capability; and * Confirmation of alcohol consumption. Exclusion Criteria: * Non-English speaker * Non-drinker * Previously enrolled in adaption phase focus-groups to determine intervention content * Clinically significant depression, as indicated by an assessment of ≥ 16 on the CES-D 11-item Iowa short form scale
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Alcohol use, unspecified are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Feinstein Institutes for Medical Research
Manhasset, New York, 11030, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a dental assistant keep cancer Patients' mouths healthier during radiation?
- Why do Non-Smokers get head and neck cancer? scientists probe tumor DNA
- Re-irradiation plus cetuximab targets head and neck tumors that return
- Sharper tumor maps: PET scans could tighten radiation beams
- Five days of radiation instead of weeks: a new test for head and neck cancer
- Can an online program ease the burden on cancer caregivers?